These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30068234)

  • 1. Erythropoietin response to anaemia in heart failure.
    Montero D; Haider T; Flammer AJ
    Eur J Prev Cardiol; 2019 Jan; 26(1):7-17. PubMed ID: 30068234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.
    Nagai T; Nishimura K; Honma T; Higashiyama A; Sugano Y; Nakai M; Honda S; Iwakami N; Okada A; Kawakami S; Kanaya T; Asaumi Y; Aiba T; Nishida Y; Kubota Y; Sugiyama D; Okamura T; Noguchi T; Kusano K; Ogawa H; Yasuda S; Anzai T;
    Eur J Heart Fail; 2016 Jul; 18(7):803-13. PubMed ID: 27126377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of anaemia among patients with heart failure at the Brazzaville University Hospital.
    Ikama MS; Nsitou BM; Kocko I; Mongo NS; Kimbally-Kaky G; Nkoua JL
    Cardiovasc J Afr; 2015; 26(3):140-2. PubMed ID: 26592909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and anaemia in a broad spectrum of patients with heart failure.
    Kleijn L; Belonje AM; Voors AA; De Boer RA; Jaarsma T; Ghosh S; Kim J; Hillege HL; Van Gilst WH; van Veldhuisen DJ; van der Meer P
    Heart; 2012 Aug; 98(16):1237-41. PubMed ID: 22730482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous erythropoietin and outcome in heart failure.
    Belonje AM; Voors AA; van der Meer P; van Gilst WH; Jaarsma T; van Veldhuisen DJ
    Circulation; 2010 Jan; 121(2):245-51. PubMed ID: 20048213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaemia among patients with congestive cardiac failure in Uganda - its impact on treatment outcomes.
    Kuule JK; Seremba E; Freers J
    S Afr Med J; 2009 Dec; 99(12):876-80. PubMed ID: 20459998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry.
    von Haehling S; Gremmler U; Krumm M; Mibach F; Schön N; Taggeselle J; Dahm JB; Angermann CE
    Clin Res Cardiol; 2017 Jun; 106(6):436-443. PubMed ID: 28229219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron deficiency contributes to resistance to endogenous erythropoietin in anaemic heart failure patients.
    Tkaczyszyn M; Comín-Colet J; Voors AA; van Veldhuisen DJ; Enjuanes C; Moliner P; Drozd M; Sierpiński R; Rozentryt P; Nowak J; Suchocki T; Banasiak W; Ponikowski P; van der Meer P; Jankowska EA
    Eur J Heart Fail; 2021 Oct; 23(10):1677-1686. PubMed ID: 34050579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis.
    Bouthoorn S; Valstar GB; Gohar A; den Ruijter HM; Reitsma HB; Hoes AW; Rutten FH
    Diab Vasc Dis Res; 2018 Nov; 15(6):477-493. PubMed ID: 30037278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relation between serum erythropoietin level and severity of disease and mortality in patients with chronic heart failure.
    Avkaroğullari M; Bozkurt A; Akpinar O; Dönmez Y; Demirtaş M
    Acta Cardiol; 2008 Jun; 63(3):297-302. PubMed ID: 18664018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study.
    Tominaga M; Kawai M; Minai K; Ogawa K; Inoue Y; Morimoto S; Tanaka T; Nagoshi T; Ogawa T; Yoshimura M
    BMJ Open; 2019 Mar; 9(3):e024194. PubMed ID: 30837249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.
    von Haehling S; van Veldhuisen DJ; Roughton M; Babalis D; de Boer RA; Coats AJ; Manzano L; Flather M; Anker SD
    Eur J Heart Fail; 2011 Jun; 13(6):656-63. PubMed ID: 21613429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment.
    Van Vlerken LG; Van Soest H; Janssen MP; Boland GJ; Drenth JP; Burger DM; Siersema PD; Van Erpecum KJ
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1308-15. PubMed ID: 20729740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.
    van der Meer P; Lok DJ; Januzzi JL; de la Porte PW; Lipsic E; van Wijngaarden J; Voors AA; van Gilst WH; van Veldhuisen DJ
    Eur Heart J; 2008 Jun; 29(12):1510-5. PubMed ID: 18495690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent impairment of the erythropoietin response to reduced central venous pressure in HFpEF patients.
    Montero D; Haider T; Barthelmes J; Goetze JP; Cantatore S; Lundby C; Sudano I; Ruschitzka F; Flammer AJ
    Physiol Rep; 2019 Mar; 7(5):e14021. PubMed ID: 30821129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
    van der Meer P; Voors AA; Lipsic E; Smilde TD; van Gilst WH; van Veldhuisen DJ
    J Am Coll Cardiol; 2004 Jul; 44(1):63-7. PubMed ID: 15234408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.
    Adlbrecht C; Kommata S; Hülsmann M; Szekeres T; Bieglmayer C; Strunk G; Karanikas G; Berger R; Mörtl D; Kletter K; Maurer G; Lang IM; Pacher R
    Eur Heart J; 2008 Oct; 29(19):2343-50. PubMed ID: 18701467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry.
    Okuno K; Naito Y; Asakura M; Sugahara M; Ando T; Yasumura S; Nagai T; Saito Y; Yoshikawa T; Masuyama T; Anzai T
    Heart Vessels; 2019 Jul; 34(7):1168-1177. PubMed ID: 30675647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction: A Holistic Proteomic Approach.
    Hage C; Michaëlsson E; Linde C; Donal E; Daubert JC; Gan LM; Lund LH
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28100627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between concentration of pathological cytokines and erythropoietin in patients with chronic heart failure with anemic syndrome].
    Zakhidova KKh
    Vestn Ross Akad Med Nauk; 2014; (1-2):32-7. PubMed ID: 25055558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.